UK oncology information system market was $150 million in 2018 and is estimated to grow at a CAGR of 9.6% over the forecast period to reach $280 million in 2025. Major factors that augment the growth of the market include a significant prevalence of cancer coupled with the increased penetration of digitalization in the healthcare sector. The increasing prevalence of cancer in the country is one of the key factors which is expected to promote the demand for advanced systems, such as oncology information systems, that can manage patient treatment schedules, treatment plans, treatment delivery, treatment summaries, and results. Well established healthcare infrastructure is also one of the key reasons which are expected to promote the implementation of oncology information system in healthcare facilities, thereby, driving the growth of the market in the near future. 

The UK Oncology Information System market is segmented on the basis of oncology type and end-user. On the basis of oncology type, the market is segmented into medical oncology, radiation oncology, and surgical oncology. Medical oncology segment dominated the market in 2018 and is further estimated to continue the same trend over the forecast period. Medical oncology includes immunotherapy, chemotherapy, targeted therapy, and hormonal therapy. With the increasing number of cancer cases, the use of these therapies increases, which in turn, drives the segmental growth of the market. 

In addition, the key players such as Elekta AB, Verian Medical Systems, Inc., and Cerner Corp., contribute significantly to the segmental growth of the market. For instance, MOSAIQ Medical Oncology system offered by Elekta AB efficiently manage all the chemotherapy program, ranging from diagnosis to treatment post-follow-up. Additionally, it manages medical record of patient for multiple treatment types and reduces errors and inefficiencies. Furthermore, based on the end-user, the market is classified into hospitals and clinics, diagnostic centers, and others. 

The UK Oncology Information System market is characterized with the presence of various players operating in the market. Some of the prominent players that contribute significantly in the market include Elekta AB, Cerner Corp., Koninklijke Philips N.V., Verian Medical Systems, Inc., Mckesson Corp., IBM Corp. and others. These players operate in very highly competitive environment and thus adopts various strategies to stay competitive in the market. Mergers and acquisitions, new product launch, geographical expansion, manufacturing capability expansion are some of the majorly adopted strategies by these market players. 

Research Methodology

The market study of the UK Oncology Information System market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Authenticate databases 
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, different products, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. UK Oncology Information System Market Research and Analysis by Oncology Type
2. UK Oncology Information System Market Research and Analysis by End-User

The Report Covers

• Comprehensive research methodology of UK Oncology Information System market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting UK Oncology Information System market.
• Insights about market determinants that are stimulating UK Oncology Information System market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.